Home / Health / Son Dies After Potent Opioid Masquerades as Kratom
Son Dies After Potent Opioid Masquerades as Kratom
14 Aug
Summary
- Concentrated 7-OH product, believed to be kratom, led to fatal overdose.
- Experts warn enhanced kratom products are driving the opioid epidemic.
- Regulatory bodies are moving to classify 7-OH as a Schedule I opioid.
A Texas family is raising awareness after their son, Sam, tragically died from a concentrated 7-Hydroxymitragynine (7-OH) product he thought was ordinary kratom. His parents emphasize that Sam was unaware of 7-OH's addictive and lethal nature, believing he was consuming a harmless substance.
This incident underscores a growing public health concern as federal regulators consider classifying 7-OH and related compounds as Schedule I opioids. Experts warn these potent substances, often sold as 'enhanced kratom' in gas stations and vape shops, pose a significant risk and could exacerbate the ongoing opioid epidemic.
Sam's family recounts how he was easily able to purchase these cheaper, stronger products, unaware of their true danger. They highlight the lack of awareness about 7-OH among local authorities and medical staff, emphasizing the need for immediate action, including product bans and public education.
Scientific assessments confirm 7-OH is a potent opioid, binding much more tightly and being significantly more potent than kratom's primary compound, mitragynine. Its concentrated forms carry severe risks, including respiratory depression and a high addiction potential, distinct from botanical kratom.
